These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6688375)

  • 1. The role of intestinal microflora in the metabolic reduction of 1-nitropyrene to 1-aminopyrene in conventional and germfree rats and in humans.
    El-Bayoumy K; Sharma C; Louis YM; Reddy B; Hecht SS
    Cancer Lett; 1983 Jul; 19(3):311-6. PubMed ID: 6688375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of ring oxidized metabolites of 1-nitropyrene in the feces and urine of germfree F344 rats.
    El-Bayoumy K; Reddy B; Hecht SS
    Carcinogenesis; 1984 Oct; 5(10):1371-3. PubMed ID: 6488459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of the carcinogen 1-nitropyrene to 1-aminopyrene by rat intestinal bacteria.
    Howard PC; Beland FA; Cerniglia CE
    Carcinogenesis; 1983 Aug; 4(8):985-90. PubMed ID: 6347427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of 1-nitropyrene by human, rat, and mouse intestinal flora: mutagenicity of isolated metabolites by direct analysis of HPLC fractions with a microsuspension reverse mutation assay.
    King LC; Kohan MJ; George SE; Lewtas J; Claxton LD
    J Toxicol Environ Health; 1990 Nov; 31(3):179-92. PubMed ID: 2231777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation of 1-nitropyrene to 1-aminopyrene and N-formyl-1-aminopyrene by the human intestinal microbiota.
    Manning BW; Cerniglia CE; Federle TW
    J Toxicol Environ Health; 1986; 18(3):339-46. PubMed ID: 3519993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of 1-nitro[U-4,5,9,10-14C]pyrene in the F344 rat.
    El-Bayoumy K; Hecht SS
    Cancer Res; 1984 Oct; 44(10):4317-22. PubMed ID: 6467193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of 1-nitropyrene in germ-free and conventional rats.
    Kinouchi T; Morotomi M; Mutai M; Fifer EK; Beland FA; Ohnishi Y
    Jpn J Cancer Res; 1986 Apr; 77(4):356-69. PubMed ID: 3084426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and DNA binding of 2-nitropyrene in the rat.
    Upadhyaya P; Roy AK; Fu PP; el-Bayoumy K
    Cancer Res; 1992 Mar; 52(5):1176-81. PubMed ID: 1737377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of intestinal microflora in metabolism of glutathione conjugates of 1-nitropyrene 4,5-oxide and 1-nitropyrene 9,10-oxide.
    Kinouchi T; Kataoka K; Miyanishi K; Akimoto S; Ohnishi Y
    Tohoku J Exp Med; 1992 Oct; 168(2):119-22. PubMed ID: 1306295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excretion and metabolism of 1-nitropyrene in rats after oral or intraperitoneal administration.
    Dutcher JS; Sun JD; Bechtold WE; Unkefer CJ
    Fundam Appl Toxicol; 1985 Apr; 5(2):287-96. PubMed ID: 3987999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo metabolism of the carcinogen 4-nitropyrene.
    Upadhyaya P; Von Tungeln LS; Fu PP; el-Bayoumy K
    Chem Res Toxicol; 1994; 7(5):690-5. PubMed ID: 7841349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of nitropolycyclic aromatic hydrocarbons by human intestinal microflora.
    Cerniglia CE; Howard PC; Fu PP; Franklin W
    Biochem Biophys Res Commun; 1984 Aug; 123(1):262-70. PubMed ID: 6477581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activities of the intestinal microflora in mice treated with antibiotics or untreated and the effects of the microflora on absorption and metabolic activation of orally administered glutathione conjugates of K-region epoxides of 1-nitropyrene.
    Kinouchi T; Kataoka K; Miyanishi K; Akimoto S; Ohnishi Y
    Carcinogenesis; 1993 May; 14(5):869-74. PubMed ID: 8504479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity of derivatives and metabolites of 1-nitropyrene: activation by rat liver S9 and bacterial enzymes.
    Ball LM; Kohan MJ; Claxton LD; Lewtas J
    Mutat Res; 1984; 138(2-3):113-25. PubMed ID: 6392870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the in vitro and in vivo hepatic metabolism of the carcinogen 1-nitropyrene.
    Howard PC; Flammang TJ; Beland FA
    Carcinogenesis; 1985 Feb; 6(2):243-9. PubMed ID: 3838267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Nitrosopyrene: an intermediate in the metabolic activation of 1-nitropyrene to a mutagen in Salmonella typhimurium TA1538.
    Heflich RH; Howard PC; Beland FA
    Mutat Res; 1985 Mar; 149(1):25-32. PubMed ID: 3883150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intestinal microflora on 2,2'-dimethyl-4-aminobiphenyl-induced carcinogenesis in F344 rats.
    Reddy BS; Watanabe K
    J Natl Cancer Inst; 1978 Nov; 61(5):1269-71. PubMed ID: 280712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro intestinal microflora-mediated metabolism of biliary metabolites from 1-nitropyrene-treated rats.
    Kinouchi T; Nishifuji K; Ohnishi Y
    Microbiol Immunol; 1987; 31(12):1145-59. PubMed ID: 3451027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative tumorigenicity of 1-nitropyrene, 1-nitrosopyrene, and 1-aminopyrene administered by gavage to Sprague-Dawley rats.
    el-Bayoumy K; Rivenson A; Johnson B; DiBello J; Little P; Hecht SS
    Cancer Res; 1988 Aug; 48(15):4256-60. PubMed ID: 3390821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity of 1-nitropyrene metabolites from lung S9.
    King LC; Kohan MJ; Ball LM; Lewtas J
    Cancer Lett; 1984 Apr; 22(3):255-62. PubMed ID: 6713366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.